|
Drugs
|
Dose (commencement)
| |
|
Aspirin
|
300 mg then 81 mg daily (Day 1)
|
97.2
|
963(87.1)
|
|
Clopidogrel
|
300 mg then 75 mg daily (Day 1)
|
97.2
|
964(87.2)
|
|
Enoxaparin (Heparin)
|
1 mg/kg twice daily (Day 1)
|
81.3
|
80.6
|
|
ACE inhibitor/ARB
|
Initiate with low dose and titrate upwards (Day 1)
|
NA
|
806(72.9)
|
|
Beta blocker
|
Initiate with low dose and titrate upwards (Day 1)
|
30.3
|
846(76.5)
|
|
Statin
|
Night time max tolerated dose (Day 1)
|
NA
|
913(82.5)
|
|
Primary PCI
|
Not applicable (not a PCI center)
|
NA
|
NA
|
|
Nitrates
|
As required
|
15.0
|
809(73.1)
|
|
Investigations
|
|
ECG
|
Daily (Day 1) at least 2
|
100.0
|
NA
|
|
Cardiac enzymes
|
Daily (Day 1) at least 2
|
67.3
|
1106(100)
|
|
Echocardiogram
|
Prior to discharge
|
NA
|
632(57.1)
|
|
EST
|
If necessary
|
NA
|
NA
|
|
Risk stratification
|
|
TIMI or GRACE score or other
|
Within 24 h
|
NA
|
NA
|
|
Surgical intervention
|
|
Early invasive NSTEMI
|
Intermediate- and high-risk patient: 24 to 48 h of admission
|
Nil
|
Nil
|
|
Late invasive NSTEMI
|
Low-risk patient: 25 to 72 h of admission
|
Nil
|
Nil
|
|
Lifestyle counseling
|
|
Diet
|
Hospital stay
|
Nil
|
4.8
|
|
Smoking
|
Hospital stay
|
Nil
|
1.9
|
|
Exercise
|
Hospital stay
|
Nil
|
1.3
|
|
Daily activity
|
Hospital stay
|
Nil
|
0.0–0.6
|
|
Cardiac rehab initiated
|
Hospital stay
|
Nil
|
0.0
|
|
Discharge medication
|
Pharmacist review day 4 and before discharge
|
Nil
|
Nil
|
